Technical / White Paper
The urgent need for qualified transport providers
In light of sobering statistics from the MHRA, WHO and others about the quality of temperature-controlled drugs and medicinal products arriving at global research sites, regulatory agencies and pharmaceutical companies alike are demanding that every party involved in the pharmaceutical supply chain − transportation and logistics providers included − conform to GxP guidelines. This article outlines the main precepts of GxP as it applies to the pharmaceutical transport industry and offers insight on securing the global CTM supply chain.
